Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1595136

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1595136

Oxidized Regenerated Cellulose Based Hemostats Market by End User (Clinic, Infectious Diseases), Distribution Channel (Direct Sales, Retail Sales) - Global Forecast 2025-2030

PUBLISHED:
PAGES: 189 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Oxidized Regenerated Cellulose Based Hemostats Market was valued at USD 182.63 million in 2023, expected to reach USD 205.07 million in 2024, and is projected to grow at a CAGR of 12.38%, to USD 413.45 million by 2030.

Oxidized Regenerated Cellulose (ORC) based hemostats are crucial bioresorbable materials primarily used to control bleeding during surgical procedures. These hemostats are favored for their quick hemostatic action and biocompatibility, making them essential for applications in surgeries where rapid blood coagulation is required. This includes applications in cardiovascular, orthopedic, and general surgeries. The end-use scope spans across hospitals, specialty clinics, and ambulatory surgical centers. The market growth for ORC-based hemostats is primarily driven by the increasing number of surgical procedures, rising awareness about advanced surgical products, and the need for minimizing operative complications. Additionally, technological advancements in hemostatic materials and the growing adoption of minimally invasive surgeries are key growth factors. However, the market's expansion could be limited by factors such as strict regulatory requirements, high costs, and the potential for inflammatory responses in certain patients. Nevertheless, ongoing research into enhancing biocompatibility and the development of composite hemostatic agents (combining ORC with other materials) present lucrative opportunities. Companies are recommended to focus on strategic partnerships with healthcare providers to expand product reach and invest in R&D to innovate with broader applications, such as in trauma care and military medical interventions. Exploring biodegradable ORC formulations that offer more control and precision during surgery could also present a significant competitive edge. For a business entering or expanding in this market, the focus should be on overcoming regulatory hurdles through compliance and gaining market trust by demonstrating improved patient outcomes. Furthermore, identifying unmet needs in rapidly growing healthcare markets, particularly in emerging economies, could offer substantial growth opportunities. The nature of the market remains competitive yet promising, with ongoing innovation and an increasing emphasis on multi-functional hemostatic solutions poised to drive future growth.

KEY MARKET STATISTICS
Base Year [2023] USD 182.63 million
Estimated Year [2024] USD 205.07 million
Forecast Year [2030] USD 413.45 million
CAGR (%) 12.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxidized Regenerated Cellulose Based Hemostats Market

The Oxidized Regenerated Cellulose Based Hemostats Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need for advance care to manage surgical wounds
    • Rapid growth in the aging population
    • Need to ensure patient safety and render rapid recovery
    • High affordability of cellulose-based hemostats
  • Market Restraints
    • Reluctance of practitioners towards new products
    • Availability of attractive substitutes
  • Market Opportunities
    • Ongoing research and development of improved hemostats
    • Increasing demand in emerging economies
  • Market Challenges
    • Patient sensitivity issues

Porter's Five Forces: A Strategic Tool for Navigating the Oxidized Regenerated Cellulose Based Hemostats Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxidized Regenerated Cellulose Based Hemostats Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxidized Regenerated Cellulose Based Hemostats Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxidized Regenerated Cellulose Based Hemostats Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxidized Regenerated Cellulose Based Hemostats Market

A detailed market share analysis in the Oxidized Regenerated Cellulose Based Hemostats Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxidized Regenerated Cellulose Based Hemostats Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxidized Regenerated Cellulose Based Hemostats Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxidized Regenerated Cellulose Based Hemostats Market

A strategic analysis of the Oxidized Regenerated Cellulose Based Hemostats Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxidized Regenerated Cellulose Based Hemostats Market, highlighting leading vendors and their innovative profiles. These include Aegis Lifesciences, Altaylar Medical, B. Braun SE, Betatech Medical, CuraMedical B.V., GELITA MEDICAL GmbH, Hangzhou Singclean Medical Products Co., Ltd., Healthium Medtech Limited, Johnson & Johnson Services, Inc., Meril Life Sciences Pvt. Ltd., and Synthesia, a.s..

Market Segmentation & Coverage

This research report categorizes the Oxidized Regenerated Cellulose Based Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on End User, market is studied across Clinic and Infectious Diseases.
  • Based on Distribution Channel, market is studied across Direct Sales and Retail Sales.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-4312A385A2FA

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for advance care to manage surgical wounds
      • 5.1.1.2. Rapid growth in the aging population
      • 5.1.1.3. Need to ensure patient safety and render rapid recovery
      • 5.1.1.4. High affordability of cellulose-based hemostats
    • 5.1.2. Restraints
      • 5.1.2.1. Reluctance of practitioners towards new products
      • 5.1.2.2. Availability of attractive substitutes
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development of improved hemostats
      • 5.1.3.2. Increasing demand in emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Patient sensitivity issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oxidized Regenerated Cellulose Based Hemostats Market, by End User

  • 6.1. Introduction
  • 6.2. Clinic
  • 6.3. Infectious Diseases

7. Oxidized Regenerated Cellulose Based Hemostats Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Direct Sales
  • 7.3. Retail Sales

8. Americas Oxidized Regenerated Cellulose Based Hemostats Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Oxidized Regenerated Cellulose Based Hemostats Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Oxidized Regenerated Cellulose Based Hemostats Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aegis Lifesciences
  • 2. Altaylar Medical
  • 3. B. Braun SE
  • 4. Betatech Medical
  • 5. CuraMedical B.V.
  • 6. GELITA MEDICAL GmbH
  • 7. Hangzhou Singclean Medical Products Co., Ltd.
  • 8. Healthium Medtech Limited
  • 9. Johnson & Johnson Services, Inc.
  • 10. Meril Life Sciences Pvt. Ltd.
  • 11. Synthesia, a.s.
Product Code: MRR-4312A385A2FA

LIST OF FIGURES

  • FIGURE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET RESEARCH PROCESS
  • FIGURE 2. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET DYNAMICS
  • TABLE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!